GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Market Cap
中文

Novartis AG (Novartis AG) Market Cap : $199,438 Mil (As of Apr. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Novartis AG's share price for the quarter that ended in Dec. 2023 was $100.97. Novartis AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,044 Mil. Therefore, Novartis AG's market cap for the quarter that ended in Dec. 2023 was $206,386 Mil.

Novartis AG's quarterly market cap increased from Jun. 2023 ($197,494 Mil) to Sep. 2023 ($198,120 Mil) and increased from Sep. 2023 ($198,120 Mil) to Dec. 2023 ($206,386 Mil).

Novartis AG's annual market cap declined from Dec. 2021 ($184,986 Mil) to Dec. 2022 ($181,959 Mil) but then increased from Dec. 2022 ($181,959 Mil) to Dec. 2023 ($206,386 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Novartis AG's Enterprise Value for Today is $211,336 Mil.


Novartis AG Market Cap Historical Data

The historical data trend for Novartis AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Market Cap Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202,950.11 201,661.08 184,986.43 181,959.19 206,385.71

Novartis AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181,959.19 182,558.11 197,494.22 198,119.62 206,385.71

Competitive Comparison of Novartis AG's Market Cap

For the Drug Manufacturers - General subindustry, Novartis AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Novartis AG's Market Cap falls into.



Novartis AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Novartis AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$100.97*2044.03
=$206,386

Novartis AG's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$100.97*2044.03
=$206,386

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (NYSE:NVS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Novartis AG Market Cap Related Terms

Thank you for viewing the detailed overview of Novartis AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (Novartis AG) Headlines

From GuruFocus

Top 5 4th Quarter Trades of BUCKHEAD CAPITAL MANAGEMENT LLC

By GuruFocus Research GuruFocus Editor 02-09-2023